Ondansetron Tablet, Orally Disintegrating
Product Images NDC 43063-857

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Ondansetron (NDC 43063-857). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (43063857)

Label for Ondansetron 4 mg orally disintegrating tablets by PD-Rx Pharmaceuticals, Inc. The package contains 2 tablets with NDC 43063-857-02. The label includes dosage strength, count, warnings to keep out of reach of children, and storage directions, along with a note to see the package insert for dosage information.*

FDA Label Image

Chemical Structure (Ondansetronod Str)

Chemical structure of ondansetron, depicting its molecular arrangement including rings and functional groups typical for this active ingredient.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.